Cell cycle control as a basis for cancer drug development (Review).

  • Authors:
    • E R McDonald
    • W S El-Deiry
  • View Affiliations

  • Published online on: May 1, 2000     https://doi.org/10.3892/ijo.16.5.871
  • Pages: 871-957
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Normal cell cycle progression relies on the cell's ability to translate extracellular signals such as mitogenic stimuli and intact extracellular matrices in order to efficiently replicate DNA and divide. Cyclin dependent kinases (cdks) respond to these signals and are largely responsible for positively pushing cells through the cell cycle. Due to their pivotal role in cell division, nature has evolved elaborate mechanisms to regulate the kinase activity of cdks. Cyclins are cdk binding partners which are required for kinase activity and their protein levels are intimately linked to the cell cycle stage. A variety of other cdk regulators such as phosphorylation events, natural inhibitors and complex stability are discussed. Phosphorylation of various cdk substrates results in diverse outcomes such as changes in gene expression, formation of prereplicative complexes and breakdown of the nuclear envelope. Cancer cells evolve in part by over-riding normal cell cycle regulation. Abnormal cdk activity is accomplished by cyclin amplification, cdk or substrate mutation as well as inactivation of inhibitors. The selective growth advantage of cancer cells also stems from amplification of positive growth signals, mutation of checkpoint and surveillance genes as well as deregulation of programmed cell death or apoptosis. The full potential of cancer therapies, such as small molecule inhibitors and gene therapy among others, focusing on our knowledge of cell cycle regulation has yet to be reached.

Related Articles

Journal Cover

May 2000
Volume 16 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
McDonald, E., & McDonald, E. (2000). Cell cycle control as a basis for cancer drug development (Review).. International Journal of Oncology, 16, 871-957. https://doi.org/10.3892/ijo.16.5.871
MLA
McDonald, E., El-Deiry, W."Cell cycle control as a basis for cancer drug development (Review).". International Journal of Oncology 16.5 (2000): 871-957.
Chicago
McDonald, E., El-Deiry, W."Cell cycle control as a basis for cancer drug development (Review).". International Journal of Oncology 16, no. 5 (2000): 871-957. https://doi.org/10.3892/ijo.16.5.871